Background: Parenteral nutrition (PN) administered via central venous catheter has been identified as an independent risk factor for central line-associated bloodstream infections (CLABSIs). The aim of this study was to provide an updated description of the relationship between PN and CLABSI and assess temporal trends in CLABSI rates for individuals who received PN from 2009-2014, after the Centers for Medicare & Medicaid declared CLABSI a "never event." Methods: Using data obtained from all adult patient discharges between January 1, 2009, and December 31, 2014, from 2 affiliated hospitals in a large health system in New York City, univariate and multivariate analyses were performed to examine the relationship between PN and CLABSIs as well as temporal trends. Results: Among 38,674 patients with central lines, 3517 developed CLABSIs and 767 patients were prescribed PN. PN was an independent risk factor for developing CLABSI among our patients (odds ratio [OR], 2.65; 95% confidence interval [CI], 2.20-3.19). The incidence of CLABSI among patients who were prescribed PN was not significantly different across the years of this study, even after adjusting for severity of illness. Conclusion: PN remains a significant risk factor for CLABSIs; further work is needed to identify effective strategies to reduce rates of CLABSI among patients receiving PN. (JPEN J Parenter Enteral Nutr. 2018;42:171-175) 
Introduction
Healthcare-associated infections (HAIs) have long been a concern for hospitals, both for the health and safety of patients as well as the financial burden for hospitals, insurers, and patients. An estimated 1 in every 25 patients has an HAI on any given day 1 ; approximately 722,000 HAIs occurred in 2011, with just over 10% of affected patients with HAIs dying during their hospitalization. 2 In a recent study, 14% of HAIs were identified as central line-associated bloodstream infections (CLABSIs). 2 CLABSIs cost up to an estimated $56,000 per patient and are associated with an increased hospital length of stay of about 3 weeks as well as an increased mortality of 14%-40%. 3, 4 Although the incidence of CLABSI has been decreasing at a national level, in part as a result of hospital-level infection control initiatives such as increased adherence to proper hand hygiene and improved catheter insertion practices, 4 there are still a considerable number each year. 2 A 2014 report from the Centers for Disease Control and Prevention (CDC) estimated that a total of 30,100 CLABSIs still occur nationally every year. 1 Parenteral nutrition (PN) administered via central venous catheter has been identified as an independent risk factor for developing CLABSIs. [5] [6] [7] A previous study in a large tertiary care hospital in New York City reported that patients who received PN This study was concluded just as the Centers for Medicare & Medicaid Services (CMS) issued new regulations related to reimbursement for CLABSI, making them a "never event." These regulations deemed that hospitals would not receive payment for added costs of caring for CLABSI or 7 other HAIs, since HAIs are preventable. 8 An exhaustive CLABSI prevention policy and protocol (Table 1) , along with extensive education and strict monitoring, has been in place at our institution since 2008. Modified as new national guidelines are issued, the policy reflects standards published by the CDC and professional organizations.
There has been no updated description of the relative risk of CLABSI among hospitalized patients receiving PN since the national policies were instituted. Therefore, the aim of this study was to describe the relationship between PN and CLABSI and assess temporal trends in CLABSI rates for patients who received PN from 2009-2014.
Methods

Study Design and Setting
Data were obtained from all adult patient discharges between January 1, 2009, and December 31, 2014, in the 2 affiliated hospitals of Columbia University Medical Center, a large health system in New York City: a 745-bed tertiary care hospital, which included 6 intensive care units (ICUs) and more than 40 operating rooms, and a 220-bed community hospital. The larger hospital averaged 44,000 discharges each year during the study period, while the smaller hospital had an average of 12,000 discharges each year. The medical center has a robust hospital system-wide infection prevention and control program, which was in place during the study period. During the years of the study, there totaled approximately 200 prescriptions for PN each year at both hospitals combined. A nutrition support team composed of physicians, dietitians, pharmacists, and nurses monitored the administration of PN. A large compounding pharmacy was used for the outsourced compounding of PN for both 
Definitions
CLABSIs were identified using previously validated computerized algorithms, which search the electronic medical record. The diagnosis is based on definitions issued by the CDC and National Healthcare Safety Network. 9, 10 For this study, CLABSI was defined as a laboratory-confirmed bloodstream infection (BSI) in a patient with a central line in place for at least 48 hours prior to the onset of symptoms and unrelated to an infection from another site. This definition was used in our previous study in which we validated by medical record review that the results were completely congruent (ie, that patients defined with this algorithm did indeed have CLABSI). 7 
Data Collection
Statistical Analysis χ
2 or Student t tests were initially performed on multiple putative risk factors, used in our prior study and derived from a review of relevant literature, to determine which had an association with CLABSI in our cohort. Variables with a P value <.05 were used to build the multivariable model. Multivariable regression analysis was performed to evaluate the relationship between PN and the occurrence of CLABSI when adjusting for variables significant in univariate analyses. To assess temporal trends, the proportion of individuals who developed a CLABSI while receiving PN, a χ 2 test was performed to detect a change in incidence year to year over the study period. To adjust for severity of illness, univariate analyses were performed on variables used as a proxy for severity of illness, including comorbid diagnoses and CCI. Variables associated with CLABSI with a P value <.05 were included in the multivariable model. Multivariable regression analysis was performed to evaluate year of PN receipt as a predictor of CLABSI when adjusting for severity of illness. All statistical analyses were performed using SAS (version 9.4; SAS Institute, Cary, NC).
Results
The analysis included a total of 38,674 patients with a central line. There were 3517 CLABSIs and 767 patients received PN during the period of this study. Individuals who received PN did not differ in CCI but were younger, were more likely to be female and have an ICU stay, and had a longer duration of catheterization than individuals who did not receive PN (Table 2) . In univariate analyses, PN, duration of catheterization, malignancy, diabetes, HIV, renal failure, history of transplant, ICU stay, and pneumonia were associated with CLABSI (Table 3) . Multivariable regression analysis demonstrated that PN (OR, 2.65; 95% CI, 2.20-3.19), catheterization duration (OR, 1.03; 95% CI, 1.02-1.03), malignancy (OR, 1.41; 95% CI, 1.27-1.57), diabetes (OR, 1.11; 95% CI, 1.02-1.21), HIV (OR, 2.27; 95% CI, 1.76-2.93), renal failure (OR, 2.45; 95% CI, 2.26-2.67), ICU stay (OR, 1.20; 95% CI, 1.11-1.30), and pneumonia (OR, 1.35; 95% CI, 1.19-1.54) were significant risk factors for the occurrence of CLABSI. History of transplant (OR, 0.41; 95% CI, 0.33-0.50) was associated with a decreased risk of CLABSI (Table 4) . The incidence of CLABSI among individuals who were prescribed PN was not significantly different across the years in this study (χ 2 , P = .51) (Figure 1 ). In addition, after adjusting for severity of illness, the year of PN receipt was not a significant predictor of the occurrence of CLABSI.
Discussion
This study confirms what others have reported, that PN is a significant risk factor for the occurrence of CLABSI. 5, 7 Beghetto et al 5 reported that individuals in their study population who received PN had a higher risk of developing CLABSI than patients who did not receive PN (relative risk [RR], 3.30; 95% CI, 1.30-8.34). Rates of CLABSI, in general, are decreasing across the nation. 12 In the same hospitals included in our study during previous years (2006) (2007) (2008) , Ippolito et al 7 found that individuals who received PN had higher odds of developing a CLABSI compared with patients who did not receive PN (OR, 4.33; 95% CI, 2.50-7.48).
While rates of PN-related CLABSI did not decrease in our cohort during the time period studied, the odds ratio reported in this study (OR, 2.65; CI, 2.20-3.19) is lower by approximately half those previously reported. A lack of decrease during the period may be due to a small sample size, given the relatively low volume of PN in our institution, or may be the result of a drop in rates due to proactive measures taken in anticipation to the CMS Hospital-Acquired Conditions Initiative. 8 Several studies have evaluated the role of the CMS initiative in the reduction of CLABSIs. Waters et al 13 observed a decrease in CLABSI rate of 11% associated with the implementation of the CMS initiative. Lee et al 14 also observed a decrease in CLABSIs after the CMS initiative. Contrary to these results, Vaz et al 15 reported no difference in the rate of CLABSI before and after the CMS initiative.
The purpose of the current study was to assess CLABSI incidence associated with PN. In this study setting, PN is ordered only by the nutrition support service, and there is an extremely low PN usage rate (average 5 per day in 1000 quaternary care hospital beds). Hence, the indications for PN were stringently evaluated by the same team over the entire study period. Despite finding a reduction in the relative contribution of PN to CLABSI compared with our prior study, these data are observational. Until randomized studies demonstrate that the safety and efficacy of PN exceed that of no intervention and/or enteral nutrition, it is important in any setting to consider alternative methods of nutrition support and strategies to reduce adverse events associated with PN.
Limitations of this study include the use of electronic medical records, which may have missing or inaccurately recorded information. Furthermore, we were able to study only diagnoses and comorbid conditions available in our databases. This is of particular concern since electronic diagnosis and procedure codes are primarily used for billing purposes. 16 No causal analysis between PN and CLABSI was performed in this study, so causality between PN and CLABSIs cannot be inferred. In addition, the results of this study cannot be generalized to populations outside of the population of patients included in this study.
Conclusions
Policy changes such as the CMS initiative have increased awareness of HAIs and pushed hospitals to make changes to reduce their occurrence. Identifying patient populations at higher risk for developing HAIs can aid hospitals to target preventive measures at those patients. Because the results of this study indicate that PN remains a significant predictor of CLABSI and the rates of CLABSI, additional preventive measures may be necessary to reduce the incidence of CLABSIs among the population of patients receiving PN.
